Lexicon Pharmaceuticals, Inc. - Common Stock (NQ:LXRX)

1.450 +0.030 (+2.11%)

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lexicon Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter...

Via Benzinga

Gaotu Techedu, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

May 30, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Gaotu Techedu Inc. (NYSE: GOTU) shares jumped 19.7% to $2.98 in pre-market...

Via Benzinga

HP, Lexicon Pharmaceuticals And 3 Stocks To Watch Heading Into Tuesday ↗

May 30, 2023

With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 29, 2023

Via Benzinga

Earnings Preview For Lexicon Pharmaceuticals ↗

May 01, 2023

Via Benzinga

Lexicon Pharmaceuticals's Return On Capital Employed Insights ↗

March 08, 2023

Via Benzinga

Earnings Preview For Lexicon Pharmaceuticals ↗

March 01, 2023

Via Benzinga

Wall Street's Counting on an FDA Nod for This Growth Stock to Nearly Double, but Should You? ↗

May 11, 2023

Lexicon is approaching a fork in the road, and it needs permission to advance.

Via The Motley Fool

Should You Buy This Growth Stock Right Now Before It Potentially Doubles? ↗

April 22, 2023

It could skyrocket or it could tank, but it probably won't be sitting still soon.

Via The Motley Fool

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 17, 2023

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

Via Benzinga

Lexicon Pharmaceuticals's Return On Capital Employed Overview ↗

December 14, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗

March 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 03, 2023

Via Benzinga

Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday ↗

March 03, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 03, 2023

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Via Benzinga

Lexicon Pharma's Pain Candidate Fails In Postherpetic Neuralgia Study ↗

December 22, 2022

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) announced the topline results of RELIEF-PHN-1 Phase 2 proof-of-concept study of LX9211 in postherpetic neuralgia, a lasting pain in the areas of the skin that...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 22, 2022

Via Benzinga

Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

December 22, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Westrock Coffee Company, LLC (NASDAQ: WEST) shares tumbled 10.9% to $11.90...

Via Benzinga

Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket ↗

December 22, 2022

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Lexicon's Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study ↗

November 15, 2022

Via Benzinga

Earnings Outlook For Lexicon Pharmaceuticals ↗

November 08, 2022

Lexicon Pharmaceuticals (NASDAQ:LXRX) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 ↗

August 12, 2022

Via Benzinga

Recap: Lexicon Pharmaceuticals Q2 Earnings ↗

August 02, 2022

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lexicon...

Via Benzinga

More Than $40 Million Bet On This Penny Stock? Check Out These 3 Penny Stocks Insiders Are Buying ↗

August 02, 2022

U.S. gold futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

This Financial Services Is Trading Higher By Over 217%; Here Are 38 Stocks Moving Premarket ↗

August 02, 2022

Gainers AMTD IDEA Group (NYSE: AMTD) rose 217.3% to $6.60 in pre-market trading after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.

Via Benzinga

Lexicon Pharmaceuticals Earnings Preview ↗

August 01, 2022

Lexicon Pharmaceuticals (NASDAQ:LXRX) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Earnings Scheduled For August 2, 2022 ↗

August 02, 2022

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Via Benzinga

Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket ↗

July 29, 2022

Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading.

Via Benzinga

This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday ↗

July 29, 2022

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.